Dr Reddy’s told the Delhi High Court it will rename its semaglutide drug from ‘Olymviq’ to ‘Olymra’ after the court raised concerns over similarity with ‘Ozempic’. The case comes as India opens its market to generic semaglutide, leading to rising trademark disputes among drugmakers.
